Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-03-28 Purchase |
2025-04-01 6:44 pm |
Perspective Therapeutics Inc. | CATX | Spoor Johan M. Chief Executive Officer |
26,676 | $2.2369 | $59,673 | 87,683 (Indirect Direct) |
View |
2025-03-28 Purchase |
2025-04-01 5:04 pm |
Perspective Therapeutics Inc. | CATX | Williamson Robert F III Director |
60,337 | $2.1902 | $132,151 | 109,348 (Indirect Direct) |
View |
2025-03-28 Purchase |
2025-04-01 5:03 pm |
Perspective Therapeutics Inc. | CATX | Graham Juan Chief Financial Officer |
33,333 | $2.2484 | $74,946 | 35,354 (Direct) |
View |
2025-03-31 Purchase |
2025-04-01 5:03 pm |
Perspective Therapeutics Inc. | CATX | Woods Lori A Director |
23,475 | $2.1299 | $49,999 | 188,267 (Indirect Direct) |
View |
2024-12-04 Purchase |
2024-12-06 4:05 pm |
Perspective Therapeutics Inc. | CATX | HENSON HEIDI Director |
25,975 | $3.85 | $100,004 | 25,975 (Indirect) |
View |
2024-12-04 Purchase |
2024-12-04 5:20 pm |
Perspective Therapeutics Inc. | CATX | Spoor Johan M. CEO |
8,000 | $3.7665 | $30,132 | 55,257 (Indirect Direct) |
View |
2024-11-25 Purchase |
2024-11-27 07:05 am |
Perspective Therapeutics Inc. | CATX | Williamson Robert F III Director |
6,266 | $3.6408 | $22,814 | 433,721 (Indirect Direct) |
View |
2024-11-25 Purchase |
2024-11-27 07:00 am |
Perspective Therapeutics Inc. | CATX | Hunt Jonathan Robert Chief Financial Officer |
12,829 | $3.8175 | $48,974 | 48,800 (Direct) |
View |
2024-11-25 Purchase |
2024-11-26 07:00 am |
Perspective Therapeutics Inc. | CATX | Spoor Johan M. CEO |
26,500 | $3.7912 | $100,468 | 228,672 (Indirect Direct) |
View |
2024-06-17 Purchase |
2024-06-18 07:48 am |
Perspective Therapeutics Inc. | CATX | Hunt Jonathan Robert Chief Financial Officer |
1,800 | $9.815 | $17,667 | 35,971 (Direct) |
View |
2024-06-14 Purchase |
2024-06-18 07:45 am |
Perspective Therapeutics Inc. | CATX | Woods Lori A Director |
4,587 | $10.9 | $49,990 | 164,792 (Indirect Direct) |
View |
2024-06-13 Purchase |
2024-06-13 5:19 pm |
Perspective Therapeutics Inc. | CATX | Spoor Johan M. CEO |
100,000 | $1.1743 | $117,430 | 207,572 (Indirect Direct) |
View |
2024-06-03 Purchase |
2024-06-04 4:02 pm |
Perspective Therapeutics Inc. | CATX | Woods Lori A Director |
34,246 | $1.4598 | $49,992 | 1,553,984 (Indirect) |
View |
2024-05-31 Purchase |
2024-06-03 4:05 pm |
Perspective Therapeutics Inc. | CATX | Hunt Jonathan Robert Chief Financial Officer |
25,006 | $1.3999 | $35,007 | 341,716 (Direct) |
View |
2024-05-31 Purchase |
2024-06-03 4:01 pm |
Perspective Therapeutics Inc. | CATX | Williamson Robert F III Director |
55,000 | $1.38 | $75,900 | 427,455 (Indirect Direct) |
View |
2024-05-29 Purchase |
2024-05-30 4:05 pm |
Perspective Therapeutics Inc. | CATX | Williamson Robert F III Director |
30,031 | $1.3324 | $40,014 | 372,455 (Indirect Direct) |
View |
2024-03-06 Purchase |
2024-03-08 11:24 am |
Perspective Therapeutics Inc. | CATX | Lantheus Alpha Therapy LLC Lantheus Holdings Inc. 10% Owner |
60,431,039 | $0.95 | $57,409,487 | 116,773,394 (Direct) |
View |
2024-01-30 Purchase |
2024-02-01 4:53 pm |
Perspective Therapeutics Inc. | CATX | Williamson Robert F III Director |
127,206 | $0.7131 | $90,710 | 342,424 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-03-03 Option Award |
2025-03-05 4:29 pm |
N/A 2035-03-03 |
Perspective Therapeutics Inc. | CATX | Puhlmann Markus Chief Medical Officer |
165,000 | $0 | 165,000 (Direct) |
View |
2025-03-03 Option Award |
2025-03-05 4:28 pm |
N/A 2035-03-03 |
Perspective Therapeutics Inc. | CATX | Hunt Jonathan Robert Chief Accounting Officer |
75,000 | $0 | 75,000 (Direct) |
View |
2025-03-03 Option Award |
2025-03-05 4:27 pm |
N/A 2035-03-03 |
Perspective Therapeutics Inc. | CATX | Spoor Johan M. Chief Executive Officer |
650,000 | $0 | 650,000 (Direct) |
View |
2025-03-03 Option Award |
2025-03-05 4:25 pm |
N/A 2035-03-03 |
Perspective Therapeutics Inc. | CATX | HENSON HEIDI Director |
50,000 | $0 | 50,000 (Direct) |
View |
2025-03-03 Option Award |
2025-03-05 4:22 pm |
N/A 2035-03-03 |
Perspective Therapeutics Inc. | CATX | Williamson Robert F III Director |
50,000 | $0 | 50,000 (Direct) |
View |
2025-03-03 Option Award |
2025-03-05 4:20 pm |
N/A 2035-03-03 |
Perspective Therapeutics Inc. | CATX | Morich Frank Director |
50,000 | $0 | 50,000 (Direct) |
View |
2025-03-03 Option Award |
2025-03-05 4:18 pm |
N/A 2035-03-03 |
Perspective Therapeutics Inc. | CATX | Woods Lori A Director |
50,000 | $0 | 50,000 (Direct) |
View |
2025-01-06 Option Award |
2025-01-07 4:50 pm |
N/A 2035-01-06 |
Perspective Therapeutics Inc. | CATX | Graham Juan Chief Financial Officer |
400,000 | $0 | 400,000 (Direct) |
View |
Ownership |
2025-01-07 4:48 pm |
N/A N/A |
Perspective Therapeutics Inc. | CATX | Graham Juan Chief Financial Officer |
0 | $0 | 2,021 (Direct) |
View |
2024-07-17 Option Award |
2024-07-19 07:36 am |
N/A 2034-07-17 |
Perspective Therapeutics Inc. | CATX | Austin Mark John VP Finance/Prin Fin&Acct Offic |
34,500 | $0 | 34,500 (Direct) |
View |
2024-06-20 Option Award |
2024-06-24 4:19 pm |
N/A 2034-06-20 |
Perspective Therapeutics Inc. | CATX | Williamson Robert F III Director |
23,000 | $0 | 23,000 (Direct) |
View |
2024-06-20 Option Award |
2024-06-24 4:15 pm |
N/A 2034-06-20 |
Perspective Therapeutics Inc. | CATX | Morich Frank Director |
23,000 | $0 | 23,000 (Direct) |
View |
2024-06-20 Option Award |
2024-06-24 4:13 pm |
N/A 2034-06-20 |
Perspective Therapeutics Inc. | CATX | Woods Lori A Director |
23,000 | $0 | 23,000 (Direct) |
View |
2024-06-20 Option Award |
2024-06-24 4:11 pm |
N/A 2034-06-20 |
Perspective Therapeutics Inc. | CATX | HENSON HEIDI Director |
23,000 | $0 | 23,000 (Direct) |
View |
2024-06-20 Option Award |
2024-06-24 4:09 pm |
N/A 2034-06-20 |
Perspective Therapeutics Inc. | CATX | Spoor Johan M. CEO |
500,000 | $0 | 500,000 (Direct) |
View |
2024-06-20 Option Award |
2024-06-24 4:07 pm |
N/A 2034-06-20 |
Perspective Therapeutics Inc. | CATX | Puhlmann Markus Chief Medical Officer |
150,000 | $0 | 150,000 (Direct) |
View |
2024-06-20 Option Award |
2024-06-24 4:05 pm |
N/A 2034-06-20 |
Perspective Therapeutics Inc. | CATX | Hunt Jonathan Robert Chief Financial Officer |
100,000 | $0 | 100,000 (Direct) |
View |
2024-04-23 Exercise |
2024-04-24 4:35 pm |
N/A 2032-08-09 |
Perspective Therapeutics Inc. | CATX | Austin Mark John VP Finance/Prin Fin&Acct Offic |
30,000 | $0 | 204,030 (Direct) |
View |
2024-04-23 Exercise |
2024-04-24 4:35 pm |
N/A N/A |
Perspective Therapeutics Inc. | CATX | Austin Mark John VP Finance/Prin Fin&Acct Offic |
30,000 | $0.36 | 204,030 (Direct) |
View |
Ownership |
2024-02-01 07:56 am |
N/A N/A |
Perspective Therapeutics Inc. | CATX | Lantheus Alpha Therapy LLC Lantheus Holdings Inc. 10% Owner |
0 | $0 | 56,342,355 (Direct) |
View |